Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Breast Cancer Cells Characterized by Microspectroscopy

By LabMedica International staff writers
Posted on 05 Nov 2012
A diagnostic tool has been developed that identifies the metastatic ability of breast cancer cells based on the characterization of the lipid component of the cells. More...


The characterization of the lipids associated with malignancy has been possible due to technological development of a spectroscopic device named Raman (RS) and forms the basis for introducing this technique in routine cytological diagnosis.

Scientists at the Bellvitge Biomedical Research Institute (IDIBELL; Barcelona, Spain) assessed the different profiling of the lipid composition of breast cancer cells, which permitted differentiation of the lipogenic phenotype according to the proportion of unsaturated fatty acids. The investigators cultured breast cancer cells and applied immunochemistry, before submitting the samples to Raman microspectroscopy

The Renishaw Raman system (Apply Innovation; Wotton-under-Edge, UK) comprises of a 514 nm laser that supplies an excitation beam of about 10 mW power, which is focused onto the sample via a microscope. The cytoplasm lipids were measured by RS in a position near the nucleus and outside the endoplasmic reticulum area, where the Nile red staining showed major lipid concentration. The lipid phenotype associated to breast cancer malignancy belongs to Raman spectra acquired in the range of 2,820-3,030 cm−1.

The authors concluded that Raman spectroscopy is a promising technique in biomedical studies due to its noninvasive character and high specificity. The cytology techniques used have found a correlation between the activation of lipogenesis, the chemical reaction leading to fatty acids in an organism, and the amount of saturated fats in metastatic cells indicating a worse prognosis and a decreased survival. The lipid content of the breast cancer cells might be a useful measure to determine various functions coupled to the progression of breast cancer. Àngels Sierra, PhD, the senior author, said, “The algorithm for the discrimination of the metastatic ability is a first step towards the stratification of breast cancer cells using this quick and reactive tool." The study was published on October 17, 2012, in the journal Public Library of Science ONE.

Related Links:

Bellvitge Biomedical Research Institute
Apply Innovation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.